SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-22-002480
Filing Date
2022-04-08
Accepted
2022-04-08 16:00:36
Documents
12
Period of Report
2022-04-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_040822.htm   iXBRL 8-K 22743
  Complete submission text file 0001171843-22-002480.txt   193496

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cytk-20220408.xsd EX-101.SCH 2974
3 XBRL LABEL FILE cytk-20220408_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cytk-20220408_pre.xml EX-101.PRE 22369
6 EXTRACTED XBRL INSTANCE DOCUMENT f8k_040822_htm.xml XML 3504
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

IRS No.: 943291317 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50633 | Film No.: 22816915
SIC: 2834 Pharmaceutical Preparations